The Food and Drug Administration agreed to give a priority review to what could be a breakthrough in treating a form of cancer that will strike 70,000 people this year. Dr. Jon LaPook has the details. Source
The Food and Drug Administration agreed to give a priority review to what could be a breakthrough in treating a form of cancer that will strike 70,000 people this year. Dr. Jon LaPook has the details. Source